Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
1.98
Dollar change
+0.02
Percentage change
1.02
%
IndexRUT P/E- EPS (ttm)-1.00 Insider Own1.76% Shs Outstand370.42M Perf Week6.45%
Market Cap733.43M Forward P/E- EPS next Y-0.18 Insider Trans54.64% Shs Float361.41M Perf Month-16.10%
Income-135.98M PEG- EPS next Q-0.08 Inst Own71.19% Short Float3.46% Perf Quarter-31.96%
Sales126.76M P/S5.79 EPS this Y64.54% Inst Trans-1.59% Short Ratio3.93 Perf Half Y3.12%
Book/sh1.52 P/B1.30 EPS next Y47.00% ROA-15.66% Short Interest12.50M Perf Year-16.46%
Cash/sh1.25 P/C1.59 EPS next 5Y- ROE-37.47% 52W Range1.57 - 3.16 Perf YTD-10.41%
Dividend Est.- P/FCF- EPS past 5Y8.72% ROI-22.34% 52W High-37.34% Beta1.68
Dividend TTM- Quick Ratio4.17 Sales past 5Y-0.06% Gross Margin49.15% 52W Low26.11% ATR (14)0.13
Dividend Ex-Date- Current Ratio4.50 EPS Y/Y TTM40.19% Oper. Margin-68.11% RSI (14)48.34 Volatility6.71% 6.70%
Employees539 Debt/Eq0.16 Sales Y/Y TTM31.27% Profit Margin-107.28% Recom1.00 Target Price3.58
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q-24.79% Payout- Rel Volume0.72 Prev Close1.96
Sales Surprise-1.01% EPS Surprise-140.21% Sales Q/Q81.30% EarningsMay 08 AMC Avg Volume3.18M Price1.98
SMA204.02% SMA50-12.33% SMA200-14.76% Trades Volume2,284,895 Change1.02%
Date Action Analyst Rating Change Price Target Change
Apr-16-24Initiated TD Cowen Buy $3.50
Apr-04-24Initiated Jefferies Buy $3.25
Jul-12-23Initiated KeyBanc Capital Markets Overweight $4
May-28-24 04:01PM
May-22-24 04:01PM
May-20-24 08:00AM
May-13-24 10:45AM
May-08-24 08:59PM
04:33PM Loading…
04:33PM
04:01PM
Apr-25-24 11:27AM
08:01AM
08:00AM
Apr-08-24 08:00AM
Apr-03-24 04:01PM
Mar-18-24 08:12AM
Mar-05-24 08:27AM
Feb-29-24 06:29AM
04:41PM Loading…
Feb-28-24 04:41PM
04:16PM
04:01PM
Feb-26-24 08:00AM
Feb-22-24 04:05PM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-08-24 08:30AM
Jan-05-24 08:46AM
Jan-04-24 10:23PM
09:44PM
Dec-29-23 05:04PM
Dec-28-23 04:16PM
Dec-26-23 03:59PM
Dec-22-23 06:57PM
08:00AM Loading…
Dec-21-23 08:00AM
Dec-20-23 09:00AM
Dec-17-23 03:37PM
Dec-12-23 04:32PM
Dec-11-23 10:37AM
Dec-06-23 11:18AM
Dec-04-23 08:00AM
Nov-09-23 05:54AM
Nov-08-23 12:47PM
06:52AM
Nov-07-23 04:23PM
04:00PM
Nov-02-23 08:30AM
Oct-25-23 08:30AM
Oct-10-23 10:22AM
Oct-05-23 02:42PM
Oct-04-23 06:49PM
08:52AM
08:00AM
Aug-09-23 09:06AM
Aug-08-23 05:36PM
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-13-23 07:33AM
Jun-14-23 07:30AM
Jun-13-23 01:30PM
May-25-23 04:05PM
May-24-23 07:11AM
06:05AM
May-18-23 07:30AM
May-15-23 07:30AM
May-10-23 02:47PM
06:16AM
May-09-23 06:11PM
04:05PM
Apr-25-23 04:30PM
Apr-20-23 05:03PM
Apr-18-23 10:42AM
Apr-17-23 08:30AM
Mar-22-23 08:30AM
Mar-15-23 08:30AM
Mar-14-23 08:30AM
Mar-01-23 04:05PM
Feb-21-23 08:30AM
Feb-17-23 06:43PM
Feb-15-23 06:01PM
Feb-14-23 04:05PM
Feb-03-23 05:30AM
Jan-31-23 08:30AM
Jan-09-23 08:30AM
Jan-03-23 08:30AM
Dec-24-22 08:01AM
Nov-28-22 08:30AM
Nov-22-22 09:20AM
Nov-11-22 05:02AM
Nov-08-22 04:05PM
Nov-07-22 04:05PM
Oct-25-22 08:30AM
Oct-13-22 08:30AM
Oct-06-22 08:30AM
Aug-25-22 04:05PM
Aug-14-22 10:38AM
Aug-08-22 04:02PM
Jul-25-22 04:30PM
Jul-04-22 11:56AM
May-05-22 04:02PM
Apr-22-22 04:02PM
Apr-11-22 08:30AM
Apr-05-22 07:30AM
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casdin Partners Master Fund, LDirectorMay 23 '24Buy2.60100,000260,00046,075,821May 28 08:45 PM
Casdin Partners Master Fund, LDirectorMay 22 '24Buy2.58150,000387,73545,975,821May 22 07:53 PM
Casdin Partners Master Fund, LDirectorMay 21 '24Buy2.56350,000895,93045,825,821May 22 07:53 PM
Casdin Partners Master Fund, LDirectorMay 20 '24Buy2.58100,000258,13045,475,821May 22 07:53 PM
Casdin Partners Master Fund, LDirectorMay 17 '24Buy2.56352,072902,04445,375,821May 17 08:11 PM
Casdin Partners Master Fund, LDirectorMay 16 '24Buy2.54500,0001,270,95045,023,749May 17 08:11 PM
Black Jeffrey G.SVP & Chief Financial OfficerMay 15 '24Option Exercise0.0052,6310138,615May 16 09:07 PM
Casdin Partners Master Fund, LDirectorMay 15 '24Buy2.57500,0001,282,55044,523,749May 17 08:11 PM
Egholm MichaelPresident & CEOApr 04 '24Option Exercise0.00196,5120422,030Apr 05 06:59 PM
Kim Hanjoon AlexChief Operating OfficerApr 04 '24Option Exercise0.0070,1830140,366Apr 05 06:58 PM
Casdin Partners Master Fund, LDirectorMar 05 '24Buy2.621,4033,66911,497,928Mar 06 07:20 PM
Casdin Partners Master Fund, LDirectorMar 04 '24Buy2.57250,000642,50011,496,525Mar 06 07:20 PM
Last Close
Jul 12 04:00PM ET
20.72
Dollar change
-0.25
Percentage change
-1.19
%
BLFS Biolife Solutions Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.43 Insider Own2.29% Shs Outstand45.17M Perf Week3.60%
Market Cap954.57M Forward P/E- EPS next Y-0.32 Insider Trans-9.55% Shs Float45.01M Perf Month-3.22%
Income-62.94M PEG- EPS next Q-0.14 Inst Own98.02% Short Float9.22% Perf Quarter21.17%
Sales137.29M P/S6.95 EPS this Y64.06% Inst Trans4.96% Short Ratio10.58 Perf Half Y22.17%
Book/sh7.30 P/B2.84 EPS next Y40.89% ROA-14.84% Short Interest4.15M Perf Year-9.40%
Cash/sh0.98 P/C21.07 EPS next 5Y10.00% ROE-18.20% 52W Range8.92 - 23.32 Perf YTD27.51%
Dividend Est.- P/FCF- EPS past 5Y0.51% ROI-17.35% 52W High-11.15% Beta1.84
Dividend TTM- Quick Ratio1.77 Sales past 5Y57.29% Gross Margin29.60% 52W Low132.28% ATR (14)1.12
Dividend Ex-Date- Current Ratio2.89 EPS Y/Y TTM58.16% Oper. Margin-39.72% RSI (14)51.43 Volatility7.16% 5.53%
Employees414 Debt/Eq0.12 Sales Y/Y TTM-15.89% Profit Margin-45.84% Recom1.00 Target Price24.78
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q29.40% Payout- Rel Volume0.61 Prev Close20.97
Sales Surprise22.00% EPS Surprise30.73% Sales Q/Q-15.85% EarningsMay 09 AMC Avg Volume392.10K Price20.72
SMA200.63% SMA500.77% SMA20024.70% Trades Volume238,488 Change-1.19%
Date Action Analyst Rating Change Price Target Change
Apr-04-24Initiated Jefferies Buy $22
Jul-11-23Initiated Craig Hallum Buy $29
Apr-25-22Upgrade Oppenheimer Perform → Outperform $28
Oct-19-21Initiated B. Riley Securities Buy $61
Oct-15-21Resumed Cowen Outperform $64
May-14-21Downgrade The Benchmark Company Buy → Hold
Mar-23-21Upgrade The Benchmark Company Hold → Buy $54
Nov-10-20Initiated KeyBanc Capital Markets Overweight $40
Sep-22-20Downgrade Oppenheimer Outperform → Perform
Sep-18-20Initiated Cowen Outperform $33
Jul-12-24 08:50AM
Jun-18-24 07:00PM
May-31-24 11:17AM
May-29-24 08:04AM
May-18-24 02:34AM
07:08AM Loading…
May-13-24 07:08AM
May-10-24 12:37PM
May-09-24 10:57PM
06:05PM
04:03PM
May-02-24 10:01AM
Apr-30-24 04:12PM
Apr-18-24 11:00AM
08:05AM
Mar-27-24 04:37PM
02:15AM Loading…
Mar-14-24 02:15AM
Mar-13-24 01:50AM
Mar-04-24 08:03AM
Mar-02-24 08:16AM
Mar-01-24 06:02AM
Feb-29-24 04:03PM
Feb-20-24 08:03AM
Jan-08-24 08:15AM
Nov-16-23 02:54AM
Nov-10-23 02:33PM
Nov-09-23 04:04PM
Nov-02-23 04:03PM
12:27AM
Oct-19-23 05:04PM
Oct-09-23 04:24AM
07:47AM Loading…
Sep-13-23 07:47AM
Aug-11-23 04:06PM
06:05AM
Aug-09-23 01:38PM
Aug-08-23 06:30PM
04:03PM
Jul-27-23 04:03PM
Jul-26-23 01:30PM
Jun-21-23 08:00PM
Jun-14-23 08:03AM
Jun-06-23 08:03AM
May-12-23 07:45AM
May-11-23 07:34AM
May-10-23 05:35PM
04:03PM
May-02-23 04:03PM
Apr-26-23 08:00PM
Mar-20-23 10:46PM
Mar-17-23 08:39AM
Mar-16-23 04:03PM
Mar-13-23 09:40AM
Mar-10-23 03:38PM
Mar-09-23 04:03PM
Mar-01-23 08:03AM
Feb-17-23 09:40AM
Jan-26-23 08:00AM
Jan-17-23 08:04AM
Jan-10-23 08:05AM
Jan-09-23 08:05AM
Jan-06-23 07:31AM
Jan-03-23 06:26AM
Dec-19-22 08:03AM
Dec-18-22 04:43PM
Dec-10-22 07:12AM
Nov-21-22 08:05AM
Nov-17-22 08:05AM
Nov-11-22 05:27AM
Nov-09-22 06:05PM
04:05PM
Nov-03-22 08:52AM
Oct-11-22 10:10AM
Oct-03-22 08:03AM
Aug-25-22 08:03AM
Aug-09-22 06:35PM
04:07PM
Aug-02-22 04:05PM
Jul-18-22 06:20AM
Jun-09-22 08:05AM
Jun-02-22 12:34PM
May-09-22 05:45PM
04:03PM
May-05-22 05:15PM
May-02-22 07:28PM
07:47AM
Apr-26-22 11:18AM
Apr-07-22 04:45PM
Mar-31-22 06:44AM
Mar-18-22 05:43PM
Mar-17-22 08:05AM
Mar-15-22 08:05AM
Mar-01-22 08:05AM
Feb-28-22 06:15PM
04:03PM
Feb-21-22 08:03AM
Feb-11-22 11:40AM
Feb-02-22 05:16AM
Feb-01-22 05:38PM
Jan-27-22 05:38PM
Jan-10-22 08:00AM
Jan-04-22 08:06AM
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aebersold SarahChief Human Resources OfficerJul 01 '24Sale21.033,00063,09061,683Jul 03 05:02 PM
Berard ToddChief Marketing OfficerJun 14 '24Sale20.1810,000201,800108,894Jun 18 05:00 PM
Wichterman TroyChief Financial OfficerMay 29 '24Sale21.7857412,502125,969May 31 05:05 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 29 '24Sale21.7851711,260318,483May 31 05:05 PM
Foster Karen A.Chief Quality and OperationsMay 29 '24Sale21.784088,886158,171May 31 05:05 PM
Aebersold SarahChief Human Resources OfficerMay 29 '24Sale21.783457,51464,683May 31 05:05 PM
Berard ToddChief Marketing OfficerMay 29 '24Sale21.783457,514118,894May 31 05:05 PM
Wichterman TroyChief Financial OfficerMay 17 '24Sale22.181152,551126,543May 21 08:13 AM
Mathew Aby J.EVP & Chief Scientific OfficerMay 17 '24Sale22.18982,174319,000May 21 08:13 AM
Foster Karen A.Chief Quality and OperationsMay 17 '24Sale22.18851,885158,579May 21 08:13 AM
Berard ToddChief Marketing OfficerMay 17 '24Sale22.18731,619119,239May 21 08:13 AM
Aebersold SarahChief Human Resources OfficerMay 17 '24Sale22.18571,26465,028May 21 08:13 AM
Berard ToddChief Marketing OfficerMay 15 '24Sale22.6710,000226,700119,312May 17 04:34 PM
Aebersold SarahChief Human Resources OfficerApr 22 '24Sale16.504106,76565,085Apr 23 07:15 PM
Wichterman TroyChief Financial OfficerApr 18 '24Sale15.3195614,636126,658Apr 23 07:14 PM
Mathew Aby J.EVP & Chief Scientific OfficerApr 18 '24Sale15.315848,941319,098Apr 23 07:14 PM
Foster Karen A.Chief Quality and OperationsApr 18 '24Sale15.314817,364158,664Apr 23 07:14 PM
Aebersold SarahChief Human Resources OfficerApr 18 '24Sale15.313485,32865,495Apr 23 07:15 PM
Berard ToddChief Marketing OfficerApr 18 '24Sale15.313325,083129,312Apr 23 07:14 PM
Berard ToddChief Marketing OfficerApr 15 '24Sale15.6710,000156,700129,644Apr 18 08:18 AM
Aebersold SarahChief Human Resources OfficerApr 01 '24Sale17.654,00070,60065,843Apr 03 05:17 PM
Berard ToddChief Marketing OfficerMar 27 '24Sale17.995159,265139,644Mar 29 05:39 PM
Mathew Aby J.EVP & Chief Scientific OfficerMar 27 '24Sale17.994548,167319,682Mar 29 05:40 PM
Foster Karen A.Chief Quality and OperationsMar 27 '24Sale17.993957,106159,145Mar 29 05:39 PM
Wichterman TroyChief Financial OfficerMar 21 '24Sale17.835209,272127,614Mar 25 05:03 PM
DuRoss AmyDirectorMar 13 '24Sale17.005,06586,10529,443Mar 13 06:37 PM
Wichterman TroyChief Financial OfficerMar 12 '24Sale16.607,249120,333128,134Mar 12 09:43 PM
DE GREEF RODERICKPresident and CEOMar 12 '24Sale16.607,249120,333461,854Mar 12 09:43 PM
Berard ToddChief Marketing OfficerMar 12 '24Sale16.607,107117,976140,159Mar 12 09:44 PM
Mathew Aby J.EVP & Chief Scientific OfficerMar 12 '24Sale16.606,521108,249320,136Mar 12 09:44 PM
DuRoss AmyDirectorMar 12 '24Sale16.866,135103,43634,508Mar 13 06:37 PM
Foster Karen A.Chief Quality and OperationsMar 12 '24Sale16.605,17785,938159,540Mar 12 09:43 PM
Aebersold SarahChief Human Resources OfficerMar 12 '24Sale16.604,36172,39369,843Mar 12 09:42 PM
Phillips GeraintSVP, Global OperationsMar 12 '24Sale16.603,59859,72765,998Mar 12 09:44 PM
Berard ToddChief Marketing OfficerMar 11 '24Sale17.424016,985147,266Mar 12 09:44 PM
Wichterman TroyChief Financial OfficerMar 11 '24Sale17.423616,289135,383Mar 12 09:43 PM
Foster Karen A.Chief Quality and OperationsMar 11 '24Sale17.423195,557164,717Mar 12 09:43 PM
Mathew Aby J.EVP & Chief Scientific OfficerMar 11 '24Sale17.423135,452326,657Mar 12 09:44 PM
Aebersold SarahChief Human Resources OfficerMar 11 '24Sale17.422694,68674,204Mar 12 09:42 PM
Phillips GeraintSVP, Global OperationsMar 11 '24Sale17.422063,58969,596Mar 12 09:44 PM
Phillips GeraintSVP, Global OperationsFeb 21 '24Sale17.351312,27358,120Feb 23 05:51 PM
Berard ToddChief Marketing OfficerFeb 21 '24Sale17.351111,926115,688Feb 23 05:51 PM
Mathew Aby J.EVP & Chief Scientific OfficerFeb 21 '24Sale17.351011,752275,214Feb 23 05:51 PM
Wichterman TroyChief Financial OfficerFeb 21 '24Sale17.35971,68364,823Feb 23 05:51 PM
Foster Karen A.Chief Quality and OperationsFeb 21 '24Sale17.35871,509123,940Feb 23 05:50 PM
Aebersold SarahChief Human Resources OfficerFeb 21 '24Sale17.35581,00641,806Feb 23 05:52 PM
Aebersold SarahChief Human Resources OfficerJan 23 '24Sale17.113365,74941,864Jan 25 05:10 PM
DE GREEF RODERICKPresident and CEOJan 19 '24Sale16.762,64244,280439,897Jan 23 05:29 PM
Wichterman TroyChief Financial OfficerJan 19 '24Sale16.762,41940,54264,920Jan 23 05:29 PM
Phillips GeraintSVP, Global OperationsJan 19 '24Sale16.761,77629,76658,251Jan 23 05:30 PM
Mathew Aby J.EVP & Chief Scientific OfficerJan 19 '24Sale16.761,45024,302275,315Jan 23 05:30 PM
Berard ToddChief Marketing OfficerJan 19 '24Sale16.761,23220,648115,799Jan 23 05:29 PM
Foster Karen A.Chief Quality and OperationsJan 19 '24Sale16.761,19820,078124,027Jan 23 05:30 PM
Aebersold SarahChief Human Resources OfficerJan 19 '24Sale16.7686214,44742,200Jan 23 05:29 PM
Mathew Aby J.EVP & Chief Scientific OfficerJan 02 '24Sale16.7569711,675276,765Jan 04 05:03 PM
Foster Karen A.Chief Quality and OperationsJan 02 '24Sale16.7560110,067125,225Jan 04 05:04 PM
Berard ToddChief Marketing OfficerJan 02 '24Sale16.754918,224117,031Jan 04 05:04 PM
Wichterman TroyChief Financial OfficerDec 22 '23Sale16.793145,27267,339Dec 28 04:46 PM
Wichterman TroyChief Financial OfficerDec 01 '23Sale12.376668,23867,112Dec 04 07:14 PM
Mathew Aby J.EVP & Chief Scientific OfficerDec 01 '23Sale12.375917,311275,961Dec 04 07:15 PM
Foster Karen A.Chief Quality OfficerDec 01 '23Sale12.374665,764125,340Dec 04 07:15 PM
Aebersold SarahChief Human Resources OfficerDec 01 '23Sale12.373944,87443,062Dec 04 07:15 PM
Berard ToddChief Marketing OfficerDec 01 '23Sale12.373944,874117,522Dec 04 07:14 PM
Phillips GeraintSVP, Global OperationsDec 01 '23Sale12.373033,74859,587Dec 04 07:14 PM
Mathew Aby J.EVP & Chief Scientific OfficerNov 13 '23Sale10.771321,422275,726Nov 15 10:41 AM
Foster Karen A.Chief Quality OfficerNov 13 '23Sale10.771141,228125,539Nov 15 10:41 AM
Phillips GeraintSVP, Global OperationsNov 13 '23Sale10.661111,18359,656Nov 15 10:41 AM
Berard ToddChief Marketing OfficerNov 13 '23Sale10.77981,055117,916Nov 15 10:41 AM
Wichterman TroyChief Financial OfficerNov 13 '23Sale10.66971,03467,480Nov 15 10:40 AM
Aebersold SarahChief Human Resources OfficerNov 13 '23Sale10.777681943,456Nov 15 10:41 AM
Rice MichaelFormer CEO and DirectorOct 30 '23Sale9.1372,603662,865347,085Nov 01 05:30 PM
Casdin Partners Master Fund, L10% OwnerOct 19 '23Buy11.19927,16510,374,9768,557,165Oct 23 05:42 PM
Rice MichaelChief Executive OfficerSep 28 '23Sale14.1683111,767418,635Oct 02 05:07 PM
Mathew Aby J.EVP & Chief Scientific OfficerSep 28 '23Sale14.166599,331273,121Oct 02 05:04 PM
Foster Karen A.Chief Quality OfficerSep 28 '23Sale14.165688,043124,767Oct 02 05:08 PM
Berard ToddChief Marketing OfficerSep 28 '23Sale14.164646,570118,014Oct 02 04:56 PM
Wichterman TroyChief Financial OfficerSep 21 '23Sale12.705396,84566,300Sep 25 04:57 PM
Rice MichaelChief Executive OfficerAug 25 '23Sale10.991,72919,002416,906Aug 29 05:53 PM
Wichterman TroyChief Financial OfficerAug 25 '23Sale10.995856,42965,933Aug 29 05:51 PM
Mathew Aby J.EVP & Chief Scientific OfficerAug 25 '23Sale10.995195,704271,220Aug 29 05:53 PM
Foster Karen A.Chief Quality OfficerAug 25 '23Sale10.994104,506124,342Aug 29 05:52 PM
Schulz MarcusChief Revenue OfficerAug 25 '23Sale10.993473,81442,097Aug 29 05:54 PM
Aebersold SarahChief Human Resources OfficerAug 25 '23Sale10.993473,81443,532Aug 29 05:48 PM
Berard ToddChief Marketing OfficerAug 25 '23Sale10.993473,814118,478Aug 29 05:50 PM
Phillips GeraintSVP, Global OperationsAug 25 '23Sale10.991791,96758,045Aug 29 05:49 PM
Rice MichaelChief Executive OfficerAug 14 '23Sale12.382773,429418,635Aug 16 04:49 PM
Mathew Aby J.EVP & Chief Scientific OfficerAug 14 '23Sale12.381802,228271,739Aug 16 04:48 PM
Foster Karen A.Chief Quality OfficerAug 14 '23Sale12.381561,931124,752Aug 16 04:46 PM
Berard ToddChief Marketing OfficerAug 14 '23Sale12.381341,659118,825Aug 16 04:48 PM
Phillips GeraintSVP, Global OperationsAug 14 '23Sale12.571091,37058,224Aug 16 04:47 PM
Schulz MarcusChief Revenue OfficerAug 14 '23Sale12.381081,33742,444Aug 16 04:49 PM
Aebersold SarahChief Human Resources OfficerAug 14 '23Sale12.381041,28843,879Aug 16 04:46 PM
Wichterman TroyChief Financial OfficerAug 14 '23Sale12.57941,18266,518Aug 16 04:47 PM
Casdin Partners Master Fund, L10% OwnerAug 09 '23Buy13.2058,465771,7447,630,000Aug 11 05:01 PM
Schulz MarcusChief Revenue OfficerJul 24 '23Sale19.5067913,24042,552Jul 26 06:09 PM
Aebersold SarahChief Human Resources OfficerJul 24 '23Sale19.504629,00943,983Jul 26 06:08 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 20 '23Option Exercise2.0610,00020,600281,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 20 '23Sale20.0710,000200,700271,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 19 '23Option Exercise2.0610,00020,600281,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 19 '23Sale20.4610,000204,600271,919Jul 24 04:35 PM
Last Close
Jul 12 04:00PM ET
4.49
Dollar change
+0.03
Percentage change
0.67
%
MXCT MaxCyte Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.35 Insider Own12.25% Shs Outstand103.96M Perf Week22.01%
Market Cap469.38M Forward P/E- EPS next Y-0.42 Insider Trans0.10% Shs Float91.74M Perf Month-4.06%
Income-36.57M PEG- EPS next Q-0.13 Inst Own72.87% Short Float4.43% Perf Quarter8.72%
Sales44.06M P/S10.65 EPS this Y-24.71% Inst Trans0.19% Short Ratio7.16 Perf Half Y-15.12%
Book/sh2.17 P/B2.07 EPS next Y9.12% ROA-13.56% Short Interest4.07M Perf Year-10.20%
Cash/sh1.51 P/C2.98 EPS next 5Y- ROE-15.42% 52W Range2.45 - 5.55 Perf YTD-4.47%
Dividend Est.- P/FCF- EPS past 5Y-16.20% ROI-14.98% 52W High-19.03% Beta-
Dividend TTM- Quick Ratio12.37 Sales past 5Y20.83% Gross Margin78.92% 52W Low83.27% ATR (14)0.24
Dividend Ex-Date- Current Ratio13.26 EPS Y/Y TTM-18.72% Oper. Margin-107.30% RSI (14)57.17 Volatility6.66% 5.83%
Employees143 Debt/Eq0.08 Sales Y/Y TTM6.80% Profit Margin-83.00% Recom1.25 Target Price8.49
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q13.52% Payout- Rel Volume0.68 Prev Close4.46
Sales Surprise51.12% EPS Surprise28.00% Sales Q/Q32.25% EarningsMay 07 AMC Avg Volume568.26K Price4.49
SMA206.50% SMA502.38% SMA2005.66% Trades Volume389,075 Change0.67%
Date Action Analyst Rating Change Price Target Change
Nov-29-23Initiated Craig Hallum Buy $7
Oct-15-21Resumed Cowen Outperform
Aug-24-21Initiated William Blair Outperform
Aug-24-21Initiated Wedbush Outperform $36
Aug-24-21Initiated Stifel Buy $18
Aug-24-21Initiated Stephens Overweight $19
Aug-24-21Initiated Cowen Outperform
Aug-24-21Initiated BTIG Research Buy $22
Jul-09-24 04:05PM
Jun-13-24 09:55AM
08:50AM
Jun-11-24 01:30AM
May-29-24 08:05AM
08:05AM Loading…
May-22-24 08:05AM
May-12-24 08:19AM
May-08-24 02:39PM
06:35AM
03:58AM
May-07-24 08:58PM
05:45PM
04:05PM
Apr-10-24 08:05AM
Apr-02-24 08:05AM
08:15AM Loading…
Mar-14-24 08:15AM
Mar-13-24 08:17AM
Mar-12-24 05:31PM
04:05PM
Mar-04-24 04:05PM
Feb-09-24 08:05AM
Jan-30-24 08:05AM
Jan-23-24 08:05AM
Jan-08-24 04:05PM
Jan-03-24 08:05AM
Jan-02-24 02:00AM
Dec-19-23 11:21AM
Dec-11-23 04:05PM
Dec-07-23 11:05AM
Dec-02-23 09:04AM
08:05AM Loading…
Nov-16-23 08:05AM
Nov-09-23 12:57PM
Nov-08-23 04:05PM
Nov-06-23 04:05PM
Oct-05-23 12:59PM
08:47AM
Oct-04-23 04:05PM
Sep-06-23 08:05AM
Sep-05-23 08:05AM
Aug-09-23 04:05PM
Aug-01-23 08:05AM
Jul-13-23 08:05AM
Jul-10-23 08:05AM
Jul-08-23 04:54AM
Jul-06-23 08:05AM
Jun-01-23 04:05PM
May-30-23 08:18AM
May-14-23 03:11AM
May-10-23 05:25PM
04:05PM
May-04-23 08:05AM
Apr-28-23 05:03AM
Apr-27-23 06:36PM
Apr-12-23 04:05PM
Apr-06-23 09:30AM
Mar-27-23 04:05PM
Mar-18-23 02:06AM
Mar-17-23 01:33AM
Mar-15-23 04:05PM
Mar-08-23 08:00AM
Mar-06-23 04:05PM
Feb-22-23 06:37PM
Feb-01-23 04:05PM
Jan-29-23 03:03AM
Jan-03-23 04:05PM
Dec-21-22 09:35AM
Dec-19-22 12:55PM
Dec-16-22 06:42AM
Dec-08-22 12:00PM
Dec-05-22 02:00AM
Nov-19-22 03:18AM
Nov-09-22 06:35PM
05:35PM
Nov-02-22 08:05AM
Oct-23-22 07:29PM
Oct-20-22 10:16AM
Oct-18-22 11:38AM
Oct-12-22 08:00AM
Sep-28-22 12:39PM
08:05AM
Sep-21-22 09:32AM
08:23AM
08:05AM
Sep-13-22 12:30PM
Sep-07-22 04:05PM
01:29AM
Aug-25-22 11:00AM
Aug-22-22 02:59AM
Aug-11-22 07:00AM
Aug-10-22 05:25PM
04:30PM
04:05PM
Jul-15-22 08:00AM
Jul-12-22 08:00AM
Jun-23-22 03:50AM
May-13-22 04:30PM
09:45AM
May-10-22 05:00AM
May-09-22 04:05PM
May-03-22 04:05PM
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Thomas M.EVP, GLOBAL SALESJul 09 '24Option Exercise1.6413,53122,20438,531Jul 10 04:15 PM
Ross Thomas M.EVP, GLOBAL SALESJul 09 '24Sale4.0313,53154,58425,000Jul 10 04:15 PM
Ross Thomas M.EVP, GLOBAL SALESJul 08 '24Option Exercise1.6419,80232,49544,802Jul 10 04:15 PM
Ross Thomas M.EVP, GLOBAL SALESJul 08 '24Sale4.0319,80279,78225,000Jul 10 04:15 PM
Johnston John JosephDirectorJun 27 '24Option Exercise2.2810,00022,778151,950Jul 01 05:18 PM
Johnston John JosephDirectorJun 27 '24Sale3.9910,00039,900141,950Jul 01 05:18 PM
Ross Thomas M.EVP, GLOBAL SALESJun 20 '24Option Exercise1.6433,33354,69958,333Jun 24 04:17 PM
Ross Thomas M.EVP, GLOBAL SALESJun 20 '24Sale4.0933,333136,46525,000Jun 24 04:17 PM
Masoud MaherPresident and CEOJun 10 '24Buy4.9070,443345,241100,000Jun 10 05:55 PM
Masoud MaherPresident and CEOJun 07 '24Buy4.8729,557143,82429,557Jun 10 05:55 PM
Johnston John JosephDirectorMar 26 '24Option Exercise2.145,00010,710125,583Mar 28 04:31 PM
Johnston John JosephDirectorMar 26 '24Sale4.415,00022,025120,583Mar 28 04:31 PM
Johnston John JosephDirectorJan 26 '24Option Exercise2.145,00010,710125,583Jan 30 04:30 PM
Johnston John JosephDirectorJan 26 '24Sale5.125,00025,585120,583Jan 30 04:30 PM
Johnston John JosephDirectorDec 26 '23Option Exercise2.145,00010,710125,583Dec 28 04:30 PM
Johnston John JosephDirectorDec 26 '23Sale4.535,00022,650120,583Dec 28 04:30 PM
Doerfler DouglasPresident and CEODec 05 '23Option Exercise0.0499,4423,978432,639Dec 06 04:15 PM
Doerfler DouglasPresident and CEODec 05 '23Sale5.1799,442514,115333,197Dec 06 04:15 PM
Doerfler DouglasPresident and CEODec 04 '23Option Exercise0.0425,0081,000358,205Dec 06 04:15 PM
Doerfler DouglasPresident and CEODec 04 '23Sale5.0125,008125,290333,197Dec 06 04:15 PM
Doerfler DouglasPresident and CEODec 01 '23Option Exercise0.0420,200808353,397Dec 01 05:14 PM
Doerfler DouglasPresident and CEODec 01 '23Sale5.0020,200101,000333,197Dec 01 05:14 PM
Doerfler DouglasPresident and CEONov 29 '23Option Exercise0.045,350214338,547Dec 01 05:14 PM
Doerfler DouglasPresident and CEONov 29 '23Sale5.005,35026,750333,197Dec 01 05:14 PM
Johnston John JosephDirectorNov 27 '23Option Exercise2.145,00010,710125,583Nov 29 04:36 PM
Johnston John JosephDirectorNov 27 '23Sale4.595,00022,950120,583Nov 29 04:36 PM
Johnston John JosephDirectorNov 14 '23Option Exercise1.7110,00017,053130,583Nov 16 04:48 PM
Johnston John JosephDirectorNov 14 '23Sale3.7110,00037,100120,583Nov 16 04:48 PM
Johnston John JosephDirectorAug 30 '23Option Exercise1.642,8414,662123,424Aug 30 05:22 PM
Johnston John JosephDirectorAug 30 '23Sale3.702,84110,512120,583Aug 30 05:22 PM
Johnston John JosephDirectorAug 29 '23Option Exercise1.642,0593,379122,642Aug 30 05:22 PM
Johnston John JosephDirectorAug 29 '23Sale3.702,0597,618120,583Aug 30 05:22 PM
Johnston John JosephDirectorAug 28 '23Option Exercise1.64100164120,683Aug 30 05:22 PM
Johnston John JosephDirectorAug 28 '23Sale3.70100370120,583Aug 30 05:22 PM
Johnston John JosephDirectorJul 26 '23Option Exercise1.645,0008,205125,583Jul 28 04:30 PM
Johnston John JosephDirectorJul 26 '23Sale4.755,00023,750120,583Jul 28 04:30 PM